ArticleLife (Basel, Switzerland)2021

CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT.

Chia-Lin Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.